Spinocerebellar Ataxia Type 2 Repeat Analysis
NY Approved
Test Overview
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Identification of at-risk family members
- Assist with treatment/management decisions
- Recurrence risk assessment
Test Details
Genes
ATXN2
Conditions
- Spinocerebellar Ataxia type 2 (SCA2)
Lab Method
- PCR Fragment Analysis
Ordering Information
Resources
Test Documents
Billing
Targeted Variant Testing